{"entity":{"type":"insider","cik":"0001262224","url":"/insider/0001262224","json_url":"/insider/0001262224.json","name":"HAYDEN BRIAN J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2007-03-07","last":"2009-02-19","span_basis":"filed_date"},"name_variants":[{"name":"HAYDEN BRIAN J","source":"filing","n_filings":9,"first_seen":"2007-03-07","last_seen":"2009-02-19"}],"transactions":[{"id":5706383,"accession":"0000950117-09-000228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-09-000228","line_url":"/filing/0000950117-09-000228#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stopck, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3441.0,"shares_display":"3,441","price_per_share":5.7659,"price_display":"5.77","price_state":"stated","total_value":19840.4619,"total_display":"19,840.46","total_whole":"19,840","shares_owned_after":11445.0,"shares_owned_after_display":"11,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-19","scope":"insider"},{"id":2333905,"accession":"0001230295-08-000270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000270","line_url":"/filing/0001230295-08-000270#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","total_whole":"120,000","shares_owned_after":14886.0,"shares_owned_after_display":"14,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-06","filed_date":"2008-05-08","scope":"insider"},{"id":3856452,"accession":"0001230295-08-000268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000268","line_url":"/filing/0001230295-08-000268#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":120000.0,"total_display":"120,000.00","total_whole":"120,000","shares_owned_after":19886.0,"shares_owned_after_display":"19,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-02","filed_date":"2008-05-06","scope":"insider"},{"id":3378673,"accession":"0001230295-08-000165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000165","line_url":"/filing/0001230295-08-000165#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2279.0,"shares_display":"2,279","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":54696.0,"total_display":"54,696.00","total_whole":"54,696","shares_owned_after":16814.0,"shares_owned_after_display":"16,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-03","scope":"insider"},{"id":3378670,"accession":"0001230295-08-000165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000165","line_url":"/filing/0001230295-08-000165#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.059,"price_display":"24.06","price_state":"stated","total_value":120295.0,"total_display":"120,295.00","total_whole":"120,295","shares_owned_after":19093.0,"shares_owned_after_display":"19,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-28","filed_date":"2008-03-03","scope":"insider"},{"id":3456978,"accession":"0001230295-08-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000136","line_url":"/filing/0001230295-08-000136#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2817.0,"shares_display":"2,817","price_per_share":19.9787,"price_display":"19.98","price_state":"stated","total_value":56279.9979,"total_display":"56,280.00","total_whole":"56,280","shares_owned_after":24093.0,"shares_owned_after_display":"24,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-15","filed_date":"2008-02-20","scope":"insider"},{"id":3868240,"accession":"0001230295-08-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001230295-08-000008","line_url":"/filing/0001230295-08-000008#line-3","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.2572,"price_display":"24.26","price_state":"stated","total_value":121286.0,"total_display":"121,286.00","total_whole":"121,286","shares_owned_after":26910.0,"shares_owned_after_display":"26,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-03","filed_date":"2008-01-04","scope":"insider"},{"id":3868239,"accession":"0001230295-08-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000008","line_url":"/filing/0001230295-08-000008#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.4721,"price_display":"23.47","price_state":"stated","total_value":117360.5,"total_display":"117,360.50","total_whole":"117,361","shares_owned_after":31910.0,"shares_owned_after_display":"31,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-02","filed_date":"2008-01-04","scope":"insider"},{"id":7279437,"accession":"0001230295-07-000786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000786","line_url":"/filing/0001230295-07-000786#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.088,"price_display":"20.09","price_state":"stated","total_value":100440.0,"total_display":"100,440.00","total_whole":"100,440","shares_owned_after":31910.0,"shares_owned_after_display":"31,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-18","filed_date":"2007-12-19","scope":"insider"},{"id":8053168,"accession":"0001230295-07-000782","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001230295-07-000782","line_url":"/filing/0001230295-07-000782#line-6","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.9075,"price_display":"19.91","price_state":"stated","total_value":99537.5,"total_display":"99,537.50","total_whole":"99,538","shares_owned_after":31910.0,"shares_owned_after_display":"31,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-17","filed_date":"2007-12-17","scope":"insider"},{"id":8053156,"accession":"0001230295-07-000782","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001230295-07-000782","line_url":"/filing/0001230295-07-000782#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.1193,"price_display":"17.12","price_state":"stated","total_value":85596.5,"total_display":"85,596.50","total_whole":"85,597","shares_owned_after":31910.0,"shares_owned_after_display":"31,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8053145,"accession":"0001230295-07-000782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000782","line_url":"/filing/0001230295-07-000782#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.1786,"price_display":"17.18","price_state":"stated","total_value":85893.0,"total_display":"85,893.00","total_whole":"85,893","shares_owned_after":31910.0,"shares_owned_after_display":"31,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-13","filed_date":"2007-12-17","scope":"insider"},{"id":7979354,"accession":"0001230295-07-000156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000156","line_url":"/filing/0001230295-07-000156#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001262224","owner_name":"HAYDEN BRIAN J","owner_display_name":"HAYDEN BRIAN J","owner_url":"/insider/0001262224","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4450.0,"shares_display":"4,450","price_per_share":12.52,"price_display":"12.52","price_state":"stated","total_value":55714.0,"total_display":"55,714.00","total_whole":"55,714","shares_owned_after":31910.0,"shares_owned_after_display":"31,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-05","filed_date":"2007-03-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Officer (SVP, Chief Financial Officer), Other","n_filings":9,"first_seen":"2007-03-07","last_seen":"2009-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001262224","retrieved_at":"2026-08-25T22:12:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}